| P50 | author | Andrea H Weinberger | Q103741608 |
| P2093 | author name string | Tony P George | |
| | Taryn G Moss | |
| | Jennifer C Vessicchio | |
| | Kristi A Sacco | |
| | Taryn M Allen | |
| P2860 | cites work | Insensitivity to future consequences following damage to human prefrontal cortex | Q28245479 |
| | The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 |
| | Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 |
| | Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data. | Q31104324 |
| | Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance | Q33635728 |
| | Co-morbidity of smoking in patients with psychiatric and substance use disorders | Q33942653 |
| | Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers | Q35793724 |
| | Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia | Q35880018 |
| | Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus | Q35956504 |
| | Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome | Q36724630 |
| | A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia | Q37218646 |
| | The Stroop effect in schizophrenic patients | Q38458217 |
| | Decision-making impairments in adolescents with early-onset schizophrenia | Q40321222 |
| | Cognitive deficits predict low treatment retention in cocaine dependent patients. | Q40387821 |
| | Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues | Q40912888 |
| | Dopamine, the prefrontal cortex and schizophrenia | Q41518710 |
| | California Verbal Learning Test practice effects in a schizophrenia sample | Q41689595 |
| | Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia | Q43562512 |
| | A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia | Q43788931 |
| | Effects of smoking abstinence on visuospatial working memory function in schizophrenia | Q43829054 |
| | A placebo controlled trial of bupropion for smoking cessation in schizophrenia | Q44038483 |
| | Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia | Q44133505 |
| | Neuropsychological function in schizophrenia. Selective impairment in memory and learning | Q44140683 |
| | Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia | Q46256992 |
| | Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys | Q46459290 |
| | Understanding the associations among education, employment characteristics, and smoking | Q46489523 |
| | Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms | Q46531414 |
| | Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients | Q48276746 |
| | Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation | Q48318584 |
| | Schizophrenics show spatial working memory deficits | Q48400844 |
| | Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication. | Q51013411 |
| | Frontal/executive impairments in schizophrenia. | Q51025858 |
| | Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. | Q51914207 |
| | Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. | Q51917938 |
| | Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. | Q51938027 |
| | Probing attentional dysfunctions in schizophrenia: Startle modification during a continuous performance test. | Q51966999 |
| | A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. | Q52013792 |
| | Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. | Q52038454 |
| | Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 |
| | Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. | Q52052088 |
| | Nicotine-haloperidol interactions and cognitive performance in schizophrenics. | Q52199316 |
| | Socio-demographic predictors of quitting smoking: how important are household factors? | Q52286182 |
| | Predictors of sustained smoking cessation: a prospective analysis of chronic smokers from the alpha-tocopherol Beta-carotene cancer prevention study | Q59196426 |
| | Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation | Q73556216 |
| | Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia | Q74091269 |
| | Smoking cessation treatment for patients with schizophrenia | Q74769931 |
| | Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000 | Q75402420 |
| | Impaired Trail-Making Test-B performance in patients with acute schizophrenia is related to inefficient sequencing of planning and acting | Q78409616 |
| P433 | issue | 1-2 | |
| P921 | main subject | schizophrenia | Q41112 |
| | cognitive dysfunction | Q57859955 |
| P304 | page(s) | 94-99 | |
| P577 | publication date | 2009-05-17 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia | |
| P478 | volume | 104 | |